Where do you come from and what are you going to become, reactive astrocyte? by M. Boccazzi & S. Ceruti
© Stem Cell Investigation. All rights reserved. Stem Cell Investig 2016;3:15sci.amegroups.com
Page 1 of 3
Astrocytes are fascinating resident cells of the central 
nervous system (CNS). They overcome neurons in number, 
and they were long believed to play a mere structural and 
homeostatic function in the healthy brain and spinal cord. 
This shortsighted view has now profoundly changed and 
astrocytes are universally recognized as one of the major 
players in the response of brain tissue to pathological 
conditions. In particular, following an acute brain 
injury (such as stroke or stab wound) but also in chronic 
degenerative pathologies, astrocytes leave their quiescent 
state and become activated (1). Reactive astrocytes undergo 
significant and substantial changes, in fact they: (I) become 
hypertrophic; (II) up-regulate intermediate filaments 
[composed of nestin, vimentin and glial fibrillary acidic 
protein (GFAP)]; (III) activate cell proliferation; and (IV) 
migrate to the site of injury to form the so-called “glial 
scar” (1). Reactive astrocytes contribute in a substantial 
way to the outcome of the lesion by releasing a plethora 
of different factors and molecules, and whether their 
reaction is beneficial or detrimental has been (and still is) 
long debated. In fact, reactive astrogliosis is undoubtedly 
important for the functional recovery of damaged tissues 
due to their release of beneficial cytokines and growth 
factors and thanks to other trophic actions favoring tissue 
remodeling and repair. Conversely, reactive astrocytes also 
contribute to the inflammatory process that can become 
overtly maladaptive when exacerbated and prolonged 
over time, like in chronic pathologies (2). Moreover, also 
the glial scar has double-edged sword characteristics: in 
fact, it physically separates the damaged tissue from the 
surviving one, thus impeding the spread of damage, but also 
inhibiting axonal regeneration (1).
A significant advance in our comprehension of the 
properties and functions of reactive astrocytes came from 
the demonstration that they can re-acquire stem cell 
properties and generate multipotent and self-renewing 
neurospheres when grown in vitro (3). Neurospheres 
are clonal floating aggregates of cells that are normally 
generated by brain neural stem cells dissected from the 
more extended neurogenic area in the adult mammalian 
brain, the ventricular-subventricular zone (V-SVZ), 
and grown in culture (4). The stem cells that generate 
neurospheres have the ability to differentiate into the three 
main brain cell types, namely neurons, astrocytes and 
oligodendrocytes. Under physiological conditions in vivo 
they predominantly give rise to neuroblasts, which migrate 
to the olfactory bulb and generate new neurons (5). 
However, traumatic and ischemic events profoundly affect 
the fate of these cells, not only by dramatically modifying 
their environment, but also by recruiting them outside their 
“natural” migratory pathway towards the injury site, in 
an often-unsuccessful attempt of regeneration (6). In fact, 
newborn neuroblasts do not functionally integrate in the 
damaged tissue, and undergo cell death very quickly.
The paper by Faiz and coworkers (7) unveils a new and 
unexpected link between reactive astrocytes and V-SVZ 
neural stem cells, by elegantly showing that in the injured 
rodent cortex only a subpopulation of reactive astrocytes 
is endowed with the stem cell-like ability to generate 
neurosphere: this subpopulation of cells was not already 
resident in the brain parenchyma, but rather migrated 
from the V-SVZ after injury. Once reached the damage 
Commentary
Where do you come from and what are you going to become, 
reactive astrocyte?
Marta Boccazzi, Stefania Ceruti
Laboratory of Molecular and Cellular Pharmacology of Purinergic Transmission, Department of Pharmacological and Biomolecular Sciences, 
Università degli Studi di Milano, via Balzaretti, 9 – 20133 Milan, Italy
Correspondence to: Stefania Ceruti. Laboratory of Molecular and Cellular Pharmacology of Purinergic Transmission, Department of Pharmacological 
and Biomolecular Sciences, Università degli Studi di Milano, via Balzaretti, 9 – 20133 Milan, Italy. Email: stefania.ceruti@unimi.it.
Received: 17 April 2016; Accepted: 27 April 2016; Published: 12 May 2016.
doi: 10.21037/sci.2016.05.02
View this article at: http://dx.doi.org/10.21037/sci.2016.05.02
1
LOGO & STYLE GUIDE
31 December 2012
Stem Cell Investigation, 2016
© Stem Cell Investigation. All rights reserved. Stem Cell Investig 2016;3:15sci.amegroups.com
Page 2 of 3
site, the majority of V-SVZ-derived cells generates reactive 
astrocytes and contributes to the formation of the glial scar, 
as previously suggested by (8). Interestingly, authors also 
demonstrated that Ascl-1, a transcription factor already 
known to convert parenchymal astrocytes to neurons (9), 
is also able to convert V-SVZ-derived reactive astrocytes 
in neurons expressing the typical neuronal markers 
doublecortin and NeuN both in vitro and in vivo, thus 
highlighting a possible new cellular conversion strategy 
aimed at enhancing neurogenesis.
Results presented in this article add diversity to the 
current knowledge on the stem cell potential of reactive 
astrocytes, and seem to contradict previous papers 
demonstrating the generation of neurospheres and new 
neurons from resident parenchymal cells after injury (1,3). 
As authors correctly state, they have employed different, 
and less severe, models of stroke with respect to already 
published data, which affect different brain areas (i.e., 
only cortex compared to both cortex and subcortical 
regions). These differences might be responsible of the 
opposite conclusions raised from data, and this is not 
surprising. While waiting for a generalization of the 
observed effects in more standard protocols of acute 
damage or even in chronic degenerative pathologies, we 
believe that the paper by Faiz et al. has the merit to have 
unveiled neural stem cells from the V-SVZ as a previously 
unforeseen source of reactive astrocytes still endowed 
with a neurogenic potential, which might have important 
clinical implications. Cells composing the V-SVZ are, 
in fact, in direct contact with the cerebrospinal fluid, 
and could therefore be reached more easily by possible 
pharmacological treatments aimed at boosting their 
neurogenic activity with respect to cells residing in the 
brain parenchyma. It has been recently demonstrated that 
human astrocytes can be reprogrammed to functional 
neurons by the in vitro administration of a cocktail of small 
molecules acting on epigenetic pathways (10). One could 
therefore envisage adopting a similar strategy targeting 
V-SVZ cells in vivo. Moreover, the transition through 
a more “reactive” state in the path to a final neuronal 
destiny could be fundamental for their correct integration 
and survival within the damages tissue, since it is driven 
by the local milieu. It is worth mentioning that, in one 
of the first published neurogenic protocols in vitro, the 
ability of glial precursor cells to generate new neurons 
was unveiled thanks to their “de-differentation” to an 
intermediate reactive astrocytes state (11), thus suggesting 
the acquisition of a genetic/epigenetic program which 
favors neurogenesis.
Taken together, a growing amount of literature data is 
helping us to understand that reactive astrocytes are actually 
a family of cells with different origins and, possibly, different 
functions and destiny. Our challenge is now to understand 
how to promote and foster their intrinsic beneficial traits 
and to reduce in parallel their detrimental functions, with 
the final aim of designing an efficient neuroreparative 
strategy for acute and chronic CNS disorders.
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